Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 12 open reading frame 10 pseudogene" (ENSG00000255965) is annotated as a pseudogene, meaning it is a genomic DNA segment that resembles a gene but is incapable of producing a functional protein product[2][6]. Pseudogenes arise through duplication or retrotransposition events, followed by mutational inactivation and loss of protein-coding potential[6]. Most pseudogenes do not have regulatory or biological functions, although rare exceptions exist[6]. This particular entry is not a receptor, enzyme, transporter, transcription factor, nor does it play a direct role in recognized physiological pathways or diseases. It does not serve as a therapeutic target or a biomarker in current medical or pharmacological practice[2][6][4].
None (no drugs act on this sequence, as it is not a functional product)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 12 open reading frame 10 pseudogene (ENSG00000255965).